Evogene (EVGN) Change in Taxes (2016 - 2026)

Evogene (EVGN) posted Change in Taxes of -$15000.0 for Q1 2026, down 36.36% sequentially from -$11000.0 in Q4 2024.

Evogene (EVGN) Change in Taxes (2016 - 2026) Analysis & Trends

Evogene has reported Change in Taxes for 10 years, with the latest figure at -$15000.0 in Q1 2026.

Quarterly Change in Taxes changed N/A year-over-year to -$15000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$47000.0 (changed N/A YoY) and the FY2025 annual result came in at -$11000.0, changed 0.0% from the prior year.
Change in Taxes eased to -$15000.0 in Q1 2026 per EVGN's latest filing, from -$11000.0 in the prior quarter.
Over five years, Change in Taxes peaked at $2000.0 in Q1 2022 and troughed at -$45000.0 in Q1 2023.
A 4-year average of -$13800.0 and a median of -$10500.0 in 2023 frame the typical range for Change in Taxes.
The widest YoY moves for Change in Taxes: up 62.96% in 2023, down 2350.0% in 2023.
Over 4 years, Change in Taxes stood at -$6000.0 in 2022, then plunged by 166.67% to -$16000.0 in 2023, then jumped by 31.25% to -$11000.0 in 2024, then sank by 36.36% to -$15000.0 in 2026.
According to Business Quant data, Change in Taxes over the past three periods registered -$15000.0, -$11000.0, and -$16000.0 for Q1 2026, Q4 2024, and Q4 2023 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Taxes (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	-
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	90.33 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Evogene	4.38 Mn	4.38 Mn	204,000.00	-15,000.00

Download Data